» Articles » PMID: 25805557

PET/MRI for the Body Imager: Abdominal and Pelvic Oncologic Applications

Overview
Journal Abdom Imaging
Date 2015 Mar 26
PMID 25805557
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this pictorial review is to describe emerging clinical applications of positron emission tomography (PET)/magnetic resonance imaging (MRI), the newest clinical hybrid imaging modality, with a specific focus on abdominal and pelvic malignancies. Important issues regarding the clinical implementation of PET/MRI systems, including workflow considerations and protocol development, are examined. The unique technical challenges of simultaneous PET/MRI acquisition and MRI-based attenuation correction are also briefly discussed. This article is intended to provide the body imager with an overview of the potential diagnostic advantages of PET/MRI, as compared to PET/CT or MRI alone.

Citing Articles

Molecular Imaging Biomarkers for Early Cancer Detection: A Systematic Review of Emerging Technologies and Clinical Applications.

Malik M, Alqahtani M, Hadadi I, Kanbayti I, Alawaji Z, Aloufi B Diagnostics (Basel). 2024; 14(21).

PMID: 39518426 PMC: 11545511. DOI: 10.3390/diagnostics14212459.


Current state of the art imaging approaches for colorectal liver metastasis.

Hazhirkarzar B, Khoshpouri P, Shaghaghi M, Ghasabeh M, Pawlik T, Kamel I Hepatobiliary Surg Nutr. 2020; 9(1):35-48.

PMID: 32140477 PMC: 7026783. DOI: 10.21037/hbsn.2019.05.11.


Quantitative performance of I PET/MR of neck lesions in thyroid cancer patients using I PET/CT as reference.

Jentzen W, Phaosricharoen J, Gomez B, Hetkamp P, Stebner V, Binse I EJNMMI Phys. 2018; 5(1):13.

PMID: 30022353 PMC: 6051951. DOI: 10.1186/s40658-018-0214-y.


Multimodality Imaging Agents with PET as the Fundamental Pillar.

Ni D, Ehlerding E, Cai W Angew Chem Int Ed Engl. 2018; 58(9):2570-2579.

PMID: 29968300 PMC: 6314921. DOI: 10.1002/anie.201806853.


Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.

Rosenkrantz A, Friedman K, Ponzo F, Raad R, Jackson K, Huang W Clin Nucl Med. 2016; 42(1):e8-e15.

PMID: 27775939 PMC: 5538348. DOI: 10.1097/RLU.0000000000001432.